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To identify genes that interact with the Drosophila homo-Trachealess—A New Transcription
log of PKB/Akt, Dakt1, a search was carried out forFactor Target for PKB/Akt mutations that were synthetic lethal in heterozygous
Dakt1 embryos. Although embryos with loss-of-function
mutations in both copies of Dakt1 or trh hatch, about
25% of embryos with one mutant copy of Dakt1 and
Applying a combined genetic and biochemical ap-
one mutant copy of trh die before hatching.proach has led to the identification of a new protein
Trh is a key regulator of the formation of the Drosophilakinase B/Akt target, the transcription factor Tra-
tracheal system, the airways that deliver oxygen fromchealess.
spiracle openings in the cuticle to the internal tissues
(Affolter and Shilo, 2000). Trh is first expressed in ten
Protein kinase B, also known as Akt and referred to here
clusters of embryonic ectodermal cells on either side of
as PKB/Akt, is a strongly conserved serine/threonine
the embryo (Isaac and Andrew, 1996; Wilk et al., 1996).kinase that plays critical roles in a wide range of cellular
These cells form tracheal placodes, invaginate into pits,processes, in particular the regulation of cellular metab-
and then elaborate into the tracheal network via a com-olism, growth, proliferation, and survival. PKB/Akt is reg-
plex series of cell invagination, migration, and fusionulated in response to elevated phosphatidylinositol 3
events. The anterior-posterior and dorsal-ventral embry-kinase (PI3 kinase) activity following stimulation with a
onic axes position the early patches of trh expression.wide range of growth factors (Brazil and Hemmings,
Later, trh positively regulates its own expression and2001; Scheid and Woodgett, 2001). PKB/Akt is also acti-
the expression of other genes involved in tracheal devel-vated in many human tumors, very often as a result of
opment such as the fibroblast growth factor receptorloss of the tumor suppressor gene product PTEN, which
homolog, breathless (btl). Trh is required for tracheal pitinhibits PI3 kinase signaling.
formation, and overexpression of Trh can induce theOwing to its central importance in several key biologi-
formation of additional tracheal placodes (Wilk et al.,cal processes and its implication in tumorigenesis, a
1996).huge amount of effort has gone into the identification
Since Dakt1 and trh interact genetically, Jin et al. ex-of substrate proteins for PKB/Akt over the past few
amined whether Dakt1 might regulate Trh activity. First,years. This has revealed a great deal, perhaps most
trh and btl expression was assessed in embryos withnotably that it is no trivial undertaking to identify true
defective Dakt1 signaling. Removing zygotic Dakt1 orphysiological targets of protein kinases. Although more
the Drosophila PI3 kinase regulatory subunit, p60, re-than 20 substrates have been reported in the literature,
duces trh and/or btl expression, as does overexpressionvery few of these are considered conclusively proven
of dominant-negative PI3 kinase or the PI3 kinase antag-to play a physiological role in the signaling downstream
onist, dPTEN. Conversely, enhancing Dakt1 signalingof PKB/Akt. The most convincingly proven substrates
by removing dPTEN expands the btl expression domain.for PKB/Akt are the FoxO subfamily of Forkhead tran-
Unfortunately, Drosophila embryos lacking both mater-scription factors (Forkead box; Kaestner et al., 2000).
nal and zygotic Dakt1 display extensive apoptosis andBiochemical, cell biological, and genetic data combine
multiple defects before tracheal pit invagination, makingto make a very strong case for these proteins being
it difficult to establish whether Dakt1 is essential for pitdirect PKB/Akt targets in mammals and worms. Phos-
invagination itself.phorylation of FoxO proteins results in their binding to
To investigate whether Dakt1 might regulate Trh di-14-3-3 proteins and exclusion from the nucleus, causing
rectly, the authors homed in on two putative PKB/Aktloss of transcriptional activity and decreased expression
consensus phosphorylation sites near the nuclear local-of proteins promoting cell death and cell cycle arrest.
ization signal of Trh. They found that mammalian PKB/In a paper published in this issue of Developmental
Akt and Drosophila Dakt1 can phosphorylate wild-typeCell, Jin et al. provide genetic and biochemical evidence
Trh, but not Trh in which one of those sites, serine 665that the Drosophila bHLH-PAS transcription factor, Tra-
chealess (Trh), is a new PKB/Akt target (Jin et al., 2001). (S665), is mutated to alanine (S665A). Unlike wild-type
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PKB/Akt Regulation of Trachealess
PKB/Akt is activated by PI3 kinase; this can
be stimulated by a range of growth factors
in different systems. Activated fly PKB/Akt
phosphorylates Trh at serine 665 close to the
nuclear localization signal (NLS), resulting in
translocation of Trh to the nucleus. In com-
plex with Tango (Tgo), a fly ARNT homolog,
Trh promotes transcription of genes involved
in trachea formation, including breathless
(btl; a fibroblast growth factor receptor) and
its own gene. As PKB/Akt can also enter the
nucleus, it is also possible that the phosphor-
ylation of Trh could occur in the nucleus.
Trh, overexpressed S665A Trh fails to activate the btl activation in the imaginal discs is likely to be stimulated
by the insulin receptor tyrosine kinase homolog DInr. Itpromoter in transactivation assays and to induce extra
patches of btl expression in embryos. Further evidence remains to be determined whether DInr is also responsi-
ble for Dakt1 activation in the developing trachea, orthat Dakt1 phosphorylates and activates Trh in vivo was
provided by the observation that in Dakt1 mutant em- whether this role is provided by other receptor tyrosine
kinases such as the fibroblast growth factor or epider-bryos, overexpressed wild-type Trh cannot induce extra
patches of btl expression, whereas Trh with S665 mu- mal growth factor receptors, which are already known
to be involved in tracheal development.tated to aspartate, to mimic phosphorylation, can.
So, how might the phosphorylation of Trh on S665 Are there implications of these results beyond the fly?
No clear ortholog of Trh exists in mammals, but theaffect its activity? Trh is normally nuclear, but when S665
is mutated to alanine, it accumulates in the cytoplasm. bHLH-PAS family of transcription factors is well repre-
Taken together, the data presented in this paper suggest sented. This includes the hypoxia-inducible transcrip-
a model in which Dakt1 positively regulates the function tion factor HIF-1, which is important in the control of
of Trh during tracheal development by phosphorylating angiogenesis, regulating the expression of vascular endo-
it and promoting its accumulation in the nucleus (see thelial growth factor. The similarities between branching
Figure). morphogenesis during fly tracheal development and
Perhaps at this point it is worth sounding a slight note mammalian angiogenesis, together with the fact that
of caution, given the history of the PKB/Akt field. The HIF-1 is reported to be activated downstream of PKB/
data presented by Jin et al. demonstrate that Dakt1 can Akt, raises the interesting possibility that, by analogy
phosphorylate Trh on S665 in vitro. They also provide with Trh, HIF-1 could be controlled by direct phosphor-
evidence that Dakt1 activity and S665 are important for ylation by PKB/Akt. However, the carboxy-terminal acti-
Trh function in vivo. However, it is still formally possible vation domain of Trh that is targeted by PKB/Akt is not
that other kinases, perhaps downstream of Dakt1, phos- conserved in HIF-1 or other mammalian bHLH-PAS
phorylate Trh in vivo, or that the observed effects of transcription factors (Crews, 1998). Although it is un-
mutation of S665 on Trh activity are caused by muta- likely that an exactly analogous regulatory system exists
tion-induced conformational changes rather than phos- in mammals, an example of phosphorylation by PKB/
phorylation-linked changes. While these possibilities do Akt promoting protein nuclear translocation has very
exist, the work gains great weight from combining ge- recently been reported for Mdm2, the ubiquitin ligase
netic and biochemical analysis and it seems likely that responsible for regulating degradation of p53 (Mayo and
Trh is indeed a genuine direct physiological target for Donner, 2001; Zhou et al., 2001). A closer look at the
PKB/Akt. effects of PKB/Akt on the nuclear localization of other
These results also identify a new function for Drosoph- transcription factors may well be rewarding, both in flies
ila Dakt1 in tracheal development. So far, Dakt1 has and in mammals.
been shown to regulate growth, cell size, and organ size
in developing imaginal discs, and cell survival in the
Julian Downward1 and Sally J. Leevers2embryo (Scheid and Woodgett, 2001). Biochemical, ge-
netic, and phenotypic analyses have shown that Akt 1 Signal Transduction Laboratory
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phosphorylates key 4 tyrosines, leading to recruitmentRetooling of the 4 Integrin
of Shc and PI3K. The importance of this HGF→Met→in Tumor Cells— 4→Shc signaling pathway is supported by findings that
(1) a Met point mutant deficient in tyrosine kinase activityLigands Lost and Kinase Gained
did not phosphorylate 4, and (2) a 4 point mutant
deficient in Shc recruitment did not show cellular re-
sponses to HGF. Notably, 4 potentiation of HGF stimu-
In carcinoma cells, the 4 integrin functions in a li- lation was not blocked by anti-4 antibody, did not re-
gand-independent manner to promote proliferation, quire 4 integrin ligand, and, in fact, did not even require
migration, and invasion. An interesting new paper (Tru- the 4 extracellular domain. Indeed, a 4 mutant lacking
solino et al., 2001) describes a mechanism whereby nearly all of its extracellular domain retained Met associ-
the 4 integrin cytoplasmic tail becomes an integrin ation and the full range of cellular responses to HGF.
ligand-independent adaptor protein for the Met recep- These results indicate definitively that 4 integrin ampli-
tor tyrosine kinase, thereby enhancing the mitogenic, fication of Met signaling is integrin ligand independent.
morphogenic, and motogenic properties of Met. While previous studies had suggested ligand-indepen-
dent 4 integrin signaling, this paper provides perhaps
Numerous studies have highlighted a role for64 integ- the clearest mechanistic insight into how such signaling
rin during carcinoma tumor progression, migration, and may occur.
invasion (reviewed in Mercurio and Rabinovitz, 2001). The 4 cytoplasmic tail provides an extended signal-
The Met tyrosine kinase, when bound with HGF ligand or ing platform, utilized for amplified HGF-triggered recruit-
spontaneously activated by mutation or overexpression, ment of the Shc adaptor protein, and phosphatidylinosi-
also is well known to promote carcinoma progression tol 3 kinase (PI3K), leading to amplified downstream
and invasion (Furge et al., 2000). A paper from Trusolino MAPK and PKB/Akt activation (see Figure). Importantly,
et al. in a recent issue of Cell now provides the first HGF-triggered recruitment of Shc and PI3K into com-
evidence that these two proinvasive molecules (Met and plexes with 4 still occurred even when kinase-active
4 integrin) are physically and functionally linked. Physi- Met was itself mutated and unable to recruit these mole-
cal interactions and functional collaborations between cules directly. Previous work has shown that ligand en-
integrins and growth factor receptors have been ob- gagement of 64 can promote tyrosine phosphoryla-
served previously (Schwartz and Baron, 1999). Typically, tion of 4 by unidentified kinases, thus leading to
such interactions are promoted by ligand occupancy recruitment of Shc and propagation of downstream sig-
of both the integrin and the growth factor receptors, naling (Dans et al., 2001). However, ligand binding to
64 was not required for HGF-Met kinase-dependentalthough sometimes integrin-dependent cell adhesion
is sufficient to activate EGF or PDGF receptors (Schwartz 4 phosphorylation and recruitment of Shc, as these
events occurred even when the 4 extracellular domainand Baron, 1999). One report described constitutive,
ligand-independent association between growth factor was deleted (Trusolino et al., 2001). Thus, by associating
with Met, the4 integrin becomes uncoupled from integ-receptor and integrin (V3), but again, functional con-
sequences of growth factor signaling were not seen until rin ligand.
The association of Met with 4 is highly specific. Ron,the integrin was engaged with ligand (Borges et al.,
2000). The paper from Trusolino et al. provides a striking a closely related growth factor receptor, did not associ-
ate with 4 and Met did not associate with 1 or 3example of integrin-growth factor collaboration that is
totally independent of integrin ligand occupancy. integrins. Given that Met-4 association strongly ampli-
fies HGF signaling leading to carcinoma invasion andTrusolino et al. show that 4 integrin associates con-
stitutively with the Met tyrosine kinase receptor in carci- proliferation, the Met-4 complex conceivably could be
a target for anticancer drug design. However, more pre-noma cell lines, thereby greatly amplifying cellular re-
sponses to the Met ligand, hepatocyte growth factor/ cise information regarding protein complex formation
needs to be obtained. For example, it is not yet knownscatter factor (HGF/SF). These 4-amplified responses
include carcinoma cell proliferation, invasion, and pro- whether the Met-4 interaction is direct. Thus far, map-
ping of Met interaction domains point to multiple Mettection from apoptosis. In response to soluble HGF, Met
